CLINICAL RESEARCH: HYPERTROPHIC CARDIOMYOPATHY
Relevance of Coronary Microvascular Flow Impairment to Long-Term Remodeling and Systolic Dysfunction in Hypertrophic Cardiomyopathy
Iacopo Olivotto, MD*,*,
Franco Cecchi, MD*,
Roberto Gistri, MD*,
Roberto Lorenzoni, MD ,
Giampaolo Chiriatti, MD ,
Francesca Girolami, BSc ,
Francesca Torricelli, BSc and
Paolo G. Camici, MD, FACC, FRCP||,¶
* Regional Referral Center for Myocardial Diseases, Florence, Italy
Cytogenetics, Azienda Ospedaliera Careggi, Florence, Italy
Cardiology Unit, Ospedale di Lucca, Lucca, Italy
Cardiology Unit, Ospedale di Pescia, Pescia, Italy
|| Consiglio Nazionale delle Ricerche, Institute of Clinical Physiology, Pisa, Italy
¶ Medical Research Council Clinical Sciences Centre, Hammersmith Hospital, Imperial College, London, United Kingdom
Manuscript received May 27, 2005;
revised manuscript received September 30, 2005,
accepted October 17, 2005.
* Reprint requests and correspondence: Dr. Iacopo Olivotto, Centro di Riferimento per le Cardiomiopatie, Cardiologia San Luca, Azienda Ospedaliera Universitaria Careggi, Viale Pieraccini 19, 50134 Firenze, Italy (Email: olivottoi{at}ao-careggi.toscana.it).
OBJECTIVES: This study sought to evaluate whether the entity of microvascular dysfunction, assessed by positron emission tomography (PET), predicts the long-term development of left ventricular (LV) remodeling and systolic dysfunction in hypertrophic cardiomyopathy (HCM).
BACKGROUND: A subgroup of patients with HCM developed LV dilation and systolic impairment. A causal role of coronary microvascular dysfunction has been suggested as the underlying pathophysiological mechanism.
METHODS: Fifty-one patients (New York Heart Association functional class I to II) were followed up for 8.1 ± 2.1 years after measurement of resting and dipyridamole (Dip) myocardial blood flow (MBF). Left ventricular systolic dysfunction was defined as an ejection fraction (LVEF) <50%.
RESULTS: The Dip-MBF was blunted in HCM patients compared with a group of healthy control patients (1.50 ± 0.69 ml/min/g vs. 2.71 ± 0.94 ml/min/g; p < 0.001). At final evaluation, 11 patients (22%) had an LVEF <50%; in most (n = 7), systolic dysfunction was associated with a significant increase in LV cavity dimensions (>5 mm) during follow-up. These 11 patients showed lower Dip-MBF than the 40 with preserved LV function (1.04 ± 0.38 ml/min/g vs. 1.63 ± 0.71 ml/min/g, respectively; p = 0.001); Dip-MBF was particularly blunted in five patients with clinical progression to severe heart failure symptoms or death (Dip-MBF 0.89 ± 0.15 ml/min/g). At multivariate analysis, the two independent predictors of systolic dysfunction were Dip-MBF in the lowest tertile (<1.1 ml/min/g; relative hazard, 7.5; p = 0.038) and an end-diastolic LV dimension in the highest tertile (>45 mm; relative hazard, 12.3; p = 0.031).
CONCLUSIONS: Severe microvascular dysfunction is a potent long-term predictor of adverse LV remodeling and systolic dysfunction in HCM. Our findings indicate microvascular dysfunction as a potential target for prevention of disease progression and heart failure in HCM.
|
Abbreviations and Acronyms
| | Dip = dipyridamole | | HCM = hypertrophic cardiomyopathy | | LV = left ventricle/ventricular | | MBF = myocardial blood flow | | NYHA = New York Heart Association | | PET = positron emission tomography |
|
This article has been cited by other articles:
|
|
|
|
 
U. Fischer-Rasokat, B. Assmus, F. H. Seeger, J. Honold, D. Leistner, S. Fichtlscherer, V. Schachinger, T. Tonn, H. Martin, S. Dimmeler, et al.
A Pilot Trial to Assess Potential Effects of Selective Intracoronary Bone Marrow-Derived Progenitor Cell Infusion in Patients With Nonischemic Dilated Cardiomyopathy: Final 1-Year Results of the Transplantation of Progenitor Cells and Functional Regeneration Enhancement Pilot Trial in Patients With Nonischemic Dilated Cardiomyopathy
Circ Heart Fail,
September 1, 2009;
2(5):
417 - 423.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Maron, I. Olivotto, B. J. Maron, S. K. Prasad, F. Cecchi, J. E. Udelson, and P. G. Camici
The case for myocardial ischemia in hypertrophic cardiomyopathy.
J. Am. Coll. Cardiol.,
August 25, 2009;
54(9):
866 - 875.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. G. Camici and O. E. Rimoldi
The Clinical Value of Myocardial Blood Flow Measurement
J. Nucl. Med.,
July 1, 2009;
50(7):
1076 - 1087.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Rudolph, H. Abdel-Aty, S. Bohl, P. Boye, A. Zagrosek, R. Dietz, and J. Schulz-Menger
Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
J. Am. Coll. Cardiol.,
January 20, 2009;
53(3):
284 - 291.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Ashrafian and H. Watkins
Exercise-induced ventricular dysfunction in hypertrophic cardiomyopathy: stunning by any other name?
Heart,
October 1, 2008;
94(10):
1251 - 1253.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Sotgia, R. Sciagra, I. Olivotto, G. Casolo, L. Rega, I. Betti, A. Pupi, P. G. Camici, and F. Cecchi
Spatial Relationship Between Coronary Microvascular Dysfunction and Delayed Contrast Enhancement in Patients with Hypertrophic Cardiomyopathy
J. Nucl. Med.,
July 1, 2008;
49(7):
1090 - 1096.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Knaapen, T. Germans, P. G. Camici, O. E. Rimoldi, F. J. ten Cate, J. M. ten Berg, P. A. Dijkmans, R. Boellaard, W. G. van Dockum, M. J. W. Gotte, et al.
Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy
Am J Physiol Heart Circ Physiol,
February 1, 2008;
294(2):
H986 - H993.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. McLeod, S. R. Ommen, M. J. Ackerman, P. L. Weivoda, W. K. Shen, J. A. Dearani, H. V. Schaff, A. J. Tajik, and B. J. Gersh
Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy
Eur. Heart J.,
November 1, 2007;
28(21):
2583 - 2588.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. I I Soliman, P. Knaapen, M. L Geleijnse, P. A Dijkmans, A. M Anwar, A. Nemes, M. Michels, W. B Vletter, A. A Lammertsma, and F. J ten Cate
Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography
Heart,
October 1, 2007;
93(10):
1204 - 1212.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Cheung, D. A. Bluemke, R. Klein, A. R. Sharrett, F.M. A. Islam, M. F. Cotch, B. E.K. Klein, M. H. Criqui, and T. Y. Wong
Retinal Arteriolar Narrowing and Left Ventricular Remodeling: The Multi-Ethnic Study of Atherosclerosis
J. Am. Coll. Cardiol.,
July 3, 2007;
50(1):
48 - 55.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. E. Petersen, M. Jerosch-Herold, L. E. Hudsmith, M. D. Robson, J. M. Francis, H. A. Doll, J. B. Selvanayagam, S. Neubauer, and H. Watkins
Evidence for Microvascular Dysfunction in Hypertrophic Cardiomyopathy: New Insights From Multiparametric Magnetic Resonance Imaging
Circulation,
May 8, 2007;
115(18):
2418 - 2425.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. G. Camici and F. Crea
Coronary Microvascular Dysfunction
N. Engl. J. Med.,
February 22, 2007;
356(8):
830 - 840.
[Full Text]
[PDF]
|
|
|
|
